INTRODUCTION
============

Spinal cord injury (SCI) often results in complete or incomplete paralysis, affecting the ability to walk and participate in physical activity. People with SCI have a sedentary lifestyle causing various complications including compromised cardiovascular function, pressure ulcers, and osteoporosis \[[@B1]\]. These factors increase morbidity and mortality in SCI. Thus, physicians have focused on treatments to improve motor function in SCI \[[@B2]\].

In the past, treatment to improve motor function in SCI was performed by physical therapists using conventional physical therapy, and focused on stretching, strengthening, and manually-assisted gait training. However, in recent decades, partial body weight support treadmill training (PBWSTT) has been used to improve gait function in patients with neurological impairment. Studies in patients with stroke indicated that PBWSTT could achieve improved gait speed, balance, and motor recovery \[[@B3][@B4]\]. PBWSTT also enabled early initiation of gait training after injury, consolidation of weight-bearing activities, and stepping and balance training by using task-specific approaches \[[@B5]\]. Rehabilitation strategies using conventional PBWSTT offer much benefit, but have some difficulties because great effort is required from a single or even two physical therapists for one patient, and result in less reproducible gait patterns and shorter duration of therapy. Thus, a mechanical system that provides PBWSTT without the need for a physical therapist, i.e., robot-assisted gait training (RAGT), was created \[[@B6][@B7]\].

Lokomat (Hocoma AG, Volketswil, Switzerland) is one of the most widely used RAGT Lokomat systems. It includes a treadmill, a body-weight support system using a harness, and two light-weight robotic arms that attach to and swing the subject\'s legs. The patient puts on the harness and two robotic arms and walks on the treadmill. The patient can also watch a monitor that provides information on progress with gait, stride, velocity, weight-bearing, and other parameters.

The Lokomat was first introduced in 2003, and has been used to improve motor function in patients with SCI \[[@B8]\]. Several studies suggested that RAGT was effective for improving gait ability in patients with motor incomplete SCI (iSCI); and one study in Korea also proposed that RAGT combined with conventional physical therapy (PT) could improve gait ability in patients with iSCI \[[@B5][@B8][@B9]\].

Most studies considered the Lower Extremity Motor Score (LEMS) as the primary outcome in examining the effects of Lokomat, since it is the most important factor in predicting future gait function in patients with iSCI \[[@B10][@B11][@B12]\]. However, several studies reported that LEMS alone did not provide sufficient information on gait function in patients with iSCI \[[@B13][@B14]\]. Moreover, there has been no report in Korea on whether patients with iSCI showed improvement in gait quality and speed with Lokomat.

Accordingly, the primary outcome was the 10-Meter Walk Test (10MWT), which reflects gait quality, including speed and agility. Patients were divided into improved and non-improved groups following robotic treatment. Clinical features that could serve as predictive factors for improvement in gait speed after robotic treatment were investigated.

MATERIALS AND METHODS
=====================

Subjects
--------

We evaluated all SCI patients who were admitted to the National Rehabilitation Center between March 2013 and February 2015. Patients who were eligible were invited to participate in the study. The inclusion criteria were (1) iSCI defined as the American Spinal Injury Association Impairment Scale (AIS) levels C and D \[[@B15]\], (2) subacute (1 to 6 months since injury) stage patients with iSCI \[[@B5]\], (3) minimum 19 years of age, and (4) able to walk independently before injury. The exclusion criteria were prior experience with RAGT; severe skeletal problems such as recent fractures, rigidity, or severe spasticity of the lower limbs; skin problem including pressure ulcers of the lower limbs or coccyx area; other neurological disorders affecting gait; medical complications such as uncontrolled cardiac disorders; pregnant or breast-feeding females; severe cognitive and/or communicative disorders; or other problems that made it impossible to properly accomplish the training.

We evaluated general characteristics in all subjects in-cluding age, sex, diagnosis, injury type (tetraplegia and paraplegia), injury cause (traumatic and non-traumatic), and time since injury. Non-traumatic injury causes included space-occupying lesions, spinal cord infarction, spinal cord abscess, and arteriovenous fistula.

Participants were informed on the purpose, protocol, and beneficial or harmful effects of the study and provided written consent. The study was approved by the National Rehabilitation Center Institutional Review Board (IRB No. NRC-2013-02-015).

Measurements
------------

All subjects were assessed before (0 week) and after training (4 weeks).

The 10MWT was measured immediately after completion of RAGT (4 weeks). Improvement following RAGT was defined as an increase in gait speed ≥0.13 m/s on the 10MWT \[[@B16]\]; a patient who was not able to perform the assessment at 0 weeks, but improved enough to perform the assessment at 4 weeks, was also considered improved. Otherwise, subjects were classified as non-improved. Lam et al. \[[@B16]\] reported that the standard error for the measure of the 10MWT was 0.05 m/s; based on this, the calculated smallest real difference of the 10MWT within the 95% confidence interval was 0.13 m/s. Thus, 0.13 m/s difference in the 10MWT is required for clinically significant difference between data. In this study, we used this value to determine actual improvement in the patient\'s 10MWT result.

Lower extremity motor function, gait ability, balance, and daily living functions were analyzed in order to identify the factors associated with the 10MWT.

LEMS was used to evaluate motor function. LEMS is the sum of bilateral lower extremity key muscle power, ranging from total paralysis (0) to normal active movement with full range of motion against gravity and full resistance (5), with a total possible score of 50 \[[@B15]\].

To evaluate gait ability, we used the measurement tools of the Functional Ambulatory Category (FAC) and the Walking Index for Spinal Cord Injury version II (WISCI-II). The FAC score ranged from 0 to 5---unable to walk (0), dependency in gait (1 or 2), gait on even and level surfaces without manual contact with another person except for safety, requires stand-by guarding, or the need for verbal cuing to complete the task (3), and independent gait over 15 meters irrespective of aids used (4 or 5) \[[@B17]\]. WISCI-II measures gait status based on the requirements for assistance and/or bracing and/or walking aids \[[@B18]\]. WISCI-II ranges from 0 to 20---grade 0, neither able to stand nor walk; and grade 20, able to walk over 10 m without walking aids, brace, or assistance.

The Berg Balance Scale (BBS) was used to evaluate balance. The BBS consists of 14 items, each ranging from not performed at all (0) to perfectly performed (4), for a total score of up to 56 \[[@B19]\]. A higher score means better balance.

Activities of daily living were measured using the Spinal Cord Independence Measurement version III (SCIM-III). SCIM-III is a disability scale for evaluating functional change in patients with SCI \[[@B20]\]. The total SCIM-III score ranges from 0 to 100, and includes the following subscales: self-care (SCIM-III-S, range 0--20), respiration and sphincter management (SCIM-III-R, 0--40), and mobility (SCIM-III-M, 0--40).

Robot-assisted gait training protocol
-------------------------------------

The Lokomat system includes a treadmill, a support system with a harness, two light-weight robotic arms attached to the legs, and a monitor showing step length, gait velocity, and other parameters.

All subjects received both RAGT on the Lokomat and conventional PT for 30 minutes, once a day, 5 times a week, for each training method, for a total of 20 sessions of RAGT.

At the beginning of treatment, the speed of the treadmill was 1.0 km/hr to 1.5 km/hr without incline, and was gradually increased as tolerated based on the rating of perceived exertion (RPE). The target RPE was 13--15 \[[@B21]\]. Support by the harness began at 50% of the subject\'s weight and was gradually decreased after they could walk safely for 30 minutes.

Statistical analysis
--------------------

Descriptive statistics were used to analyze the demographic and injury data of all subjects. Independent t-test was used to evaluate the age and time after injury, and crosstab analysis was used to evaluate the injury data in each group. We used Fisher exact test since the categories with expected frequency below 5 were over 20%. The independent t-test was used for analysis of baseline function in each group. A receiver operating characteristic (ROC) curve was used to deduct the cut-off value of baseline measurements for prediction of improvement after RAGT.

All statistical analyses were conducted using SPSS ver. 20 for Windows (IBM, Armonk, NY, USA). Data were presented as mean±standard deviation unless otherwise stated. A p-value\<0.05 was considered statistically significant.

RESULTS
=======

Subject characteristics
-----------------------

Between March 2013 and February 2015, a total of 82 patients with subacute iSCI were screened and 32 were eligible for the study. Three dropped out after initiation of the study: one subject wanted to quit the study, another dropped out because of poor health not associated with RAGT, and the other dropped out because of loss of contact. A total 29 subjects were finally included ([Fig. 1](#F1){ref-type="fig"}).

Demographic and injury data of all subjects were presented in [Table 1](#T1){ref-type="table"}. The average age was 49.9 years and all subjects were males. Nine subjects had AIS-C and 20 had AIS-D. Nineteen subjects had tetraplegia and 10 had paraplegia. There were 22 subjects with traumatic and 7 with non-traumatic SCI. Average time since injury were 15.2 weeks ([Table 1](#T1){ref-type="table"}).

Demographic data
----------------

After training (4 weeks), subjects were divided into improved group (18 subjects) and non-improved group (11 subjects) based on the 10MWT ([Fig. 1](#F1){ref-type="fig"}). In the improved group, 9 of 18 subjects were patients who had not accomplished 10MWT during the pre-test but carried out the 10MWT at post-test. The improved group had younger average age and shorter average time since injury than the non-improved group (46.7 years, 13.8 weeks and 55.2 years, 17.4 weeks, respectively). Result from the Fisher exact test indicated a significant difference in AIS scale between the improved and non-improved groups (p=0.032). However, paralysis type showed no statistical difference between both groups. All subjects with AIS-C tetraplegia belonged to the non-improved group. No significant difference was found in injury cause in both groups ([Table 2](#T2){ref-type="table"}).

Baseline function
-----------------

For analysis of the difference in baseline functions, we compared baseline assessments (0 week) between the improved and non-improved groups. The improved group showed greater basal lower extremity strength with a mean LEMS of 30.1, as compared to 22.6 in the non-improved group (p=0.018); the improved group also showed greater change in baseline balance with a mean BBS of 26.6, as compared to 12.5 in the non-improved group (p=0.033). The improved group showed higher total SCIM-III score than the non-improved group (62.3 vs. 34.7; p=0.006); even when divided into subscales, the improved group showed higher scores than the non-improved group with respect to SCIM-III-S, SCIM-III-R, and SCIM-III-M (p\<0.05). No significant differences in FAC and WISCI-II were found between groups ([Table 3](#T3){ref-type="table"}).

ROC curve
---------

Based on the results in [Table 3](#T3){ref-type="table"}, ROC curve analysis for LEMS, BBS, SCIM-III, SCIM-III-S, SCIM-III-R, and SCIM-III-M showed significant findings (p\<0.05).

The values that had both high sensitivity and high specificity were 22.5 in LEMS (sensitivity 88.9%, specificity 45.5%), 7 in BBS (sensitivity 94.4%, specificity 63.6%), and 37 in SCIM-III (sensitivity 83.3%, specificity 81.8%). In the SCIM-III subscales, the values that had both high sensitivity and high specificity were 1.5 in SCIM-III-S (sensitivity 88.9%, specificity 81.8%), 27.5 in SCIM-III-R (sensitivity 88.9%, specificity 63.6%), and 5.5 in SCIM-III-M (sensitivity 83.3%, specificity 81.8%).

DISCUSSION
==========

In this study, improvement in gait speed with 10MWT as the primary outcome were used to evaluate the effects of robotic treatment from a new perspective as compared to prior reports \[[@B5][@B8][@B9]\]. In addition to LEMS and WISCI-II, various assessment tools such as FAC, BBS, and SCIM-III were used for the ROC curve. To our best knowledge, this is a novel approach to identifythe cut-off values for baseline functions that can predict the effects of robotic treatment.

The 10MWT, Timed Up and Go test (TUG), and 6-Minute Walk Test (6MWT) are used to evaluate gait ability in subjects with iSCI quantitatively \[[@B22]\]. The 10MWT and TUG are used more than the 6MWT because they are quick and easy to perform \[[@B23][@B24]\]. We used the 10MWT as the primary outcome because it is safer and easier than the TUG, and does not have a ceiling effect \[[@B22][@B25]\].

Age, time since injury and AIS scale were previously identified as factors that significantly influence the recovery of gait ability following iSCI \[[@B26][@B27][@B28][@B29][@B30]\]. Our study concurred with the above findings, which showed that the members of the improved group were younger and had shorter time since injury than those in the non-improved group (p\<0.05). Additionally, subjects with AIS-D showed greater improvements than those with AIS-C. However, there was no statistically significant difference in paralysis type between the two groups. Interestingly, 5 patients with AIS-C tetraplegia showed no improvement, which can be explained in terms of trunk control, which is an important factor that affects gait \[[@B31]\]. The patients with AIS-C tetraplegia showed no improvement after robotic treatment, possibly because they had poorer trunk control as compared to other patients with iSCI.

LEMS is the most important factor in predicting gait ability in patients with iSCI, as confirmed in our study \[[@B10][@B11][@B12]\]. A previous study indicated that the prospects for gait improvement are poor if LEMS is ≤20 and good if ≥30 \[[@B10]\]. In this study, ROC curve analysis showed that LEMS of 23 was the cut-off value to predict the effects of RAGT, which corresponded to previous studies. Thus, LEMS ≥23 can predict improvement in gait speed after RAGT.

In our study, the baseline SCIM-III score was higher in the improved group than in the non-improved group. Balance was also a very important factor for gait ability in patients with iSCI. Balance affected gait speed, posture, endurance, and use of assistive devices in patients with iSCI \[[@B25]\], and was highly associated with gait ability in patients with chronic SCI \[[@B32]\]. Also, patients with iSCI have slower gait speed in order to maintain the center of mass within the base of support \[[@B33]\]. Balance thus has a significant influence on gait speed in patients with iSCI. The improved group had greater improvement in gait speed possibly due to better baseline balance than the non-improved group.

When measuring the ROC curve for BBS, the cut-off value was 7 points. The total possible score of the BBS test is 56, and the tasks become more difficult and challenging for patients with iSCI in the latter parts of the test \[[@B25]\]. Consequently, the BBS score of 7 points was achieved from the categories of sit to stand, stand to sit, and static standing balance or transfer \[[@B19]\].

Baseline SCIM-III score was higher in the improved group than the non-improved group (p=0.006); moreover, significant differences in SCIM-III-S, SCIM-III-R, and SCIM-III-M were observed (p\<0.05).

When the ROC curve was measured for SCIM-III-M alone, 5.5 was the cut-off value. SCIM-III-M measures categories of bed mobility, transfer, and indoor/outdoor gait, and low scores for this assessment were seen for bed mobility and transfers \[[@B20]\]. Consequently, a BBS higher than 7 and SCIM-III-M higher than 6 means that patients with some degree of static standing balance and transfer, or at least some trunk control, showed improvement in gait speed after robotic treatment.

Balance is also essential in daily life. SCI patients need static or dynamic balance for sitting, wheelchair manipulation, and daily living skills \[[@B34]\]. Thus, the difference in balance contributed to the difference in SCIM-III-S between the improved and non-improved groups. Ultimately, patients who had better baseline balance showed greater improvement in gait speed.

In this study, the baseline score of SCIM-III-R also showed significant differences in each group. However, it is difficult to interpret this result. Respiration components in SCIM-III-R scored maximum for all subjects. Thus, other components of self-care such as intermittent catheterization in urinary sphincter management, suppository use in anal sphincter management, and toilet use that are associated with balance including trunk control could have made a meaningful difference in each group.

Unlike LEMS baseline scores, there were no differences in FAC and WISCI-II between the two groups. This is contradictory to the concept that gait speed should be the primary outcome. However, FAC was scored using only 6 levels, and did not adjust for assistance or braces and walking aids; therefore, FAC did not reflect subtle changes in gait ability \[[@B17]\]. In contrast, WISCI-II classified 21 levels, with more detail than FAC. However, according to Lam et al. \[[@B16]\], 17% of patients experienced a ceiling effect and 53% of patients showed flooring effects in WISCI-II. In this study, 4 of 29 subjects had 0 point and 2 of 29 had 20 points in both pre- and post-tests. In addition, WISCI-II score was biased because of a predisposition toward setting the scores around a specific score. According to Morganti et al. \[[@B35]\], score of WISCI-II was frequently concentrated on scores of 13, 16 and 20, as seen in our study. These factors could have resulted in no significant difference in WISCI-II.

Our study had several limitations as follows: (1) the small number of subjects, (2) all subjects received both conventional PT and RAGT, which makes it difficult to determine whether the improvement is solely from RAGT or also from the conventional PT.

Recently, studies on robotic treatment for patients with iSCI have been actively conducted and effects have been demonstrated. LEMS is an important factor for independent gait for patients with iSCI. However, balance is also an important factor because it reflects not only LEMS but also trunk control ability and proprioception. As seen in this study, patients with better balance showed greater improvements in gait speed. Our study is the first to show that patients with BBS scores above 7 had higher improvement ratio in gait speed. Therefore, baseline balance can be viewed as an important factor in predicting improvement in gait speed after robotic treatment. In the future, assessment of SCIM-III, BBS, and trunk control, in addition to LEMS, will be helpful in predicting the effects of robotic treatment in patients with iSCI.
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###### General characteristics (n=29)
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Values are presented as mean±standard deviation or number (%).

AIS, American Spinal Injury Association impairment scale.

###### General characteristics of the experimental groups
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Values are presented as mean±standard deviation or number (%).

AIS, American Spinal Injury Association impairment scale.

^\*^p\<0.05.

###### Baseline functional abilities at start of RAGT
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RAGT, robot-assisted gait training; LEMS, Lower Extremity Motor Score; WISCI-II, Walking Index for Spinal Cord Injury version II; FAC, Functional Ambulatory Category; BBS, Berg Balance Scale; SCIM-III, Spinal Cord Independence Measurement version III; SCIM-III-S, self-care subscale; SCIM-III-R, respiration and sphincter control subscale; SCIM-III-M, mobility subscale.

^\*^p\<0.05, ^\*\*^p\<0.01.
